NCT01382225View on ClinicalTrials.gov

Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

1,936

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Dry Eye Syndrome

Interventions

DRUG

Sodium Hyaluronate Ophthalmic Solution, 0.18%

OTHER

Vehicle

Inactive ingredients used as run-in and placebo comparator

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY